Flu 2009 VFA
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- HHSD200200929439I
- Awardee
-
Glaxosmithkline Holdings (Americas) Inc. UEI QQH9KHXNCG81
- Awarding agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Task orders
- 0
Award facts
- Last date to order 100% complete
- IDV ceiling
- $18,843,626.15
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This indefinite delivery contract, awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency, aims to procure products and services related to the FLU 2009 Vaccine Formal Agreement (FLU 2009 VFA) program. The single-award contract, which has a ceiling value of $18,843,626.15 and a period of performance ending on February 28, 2010, was awarded to GlaxoSmithKline Holdings (Americas) Inc. on April 24, 2009. The contract does not utilize any set-asides. The specific products and services to be delivered under this contract are not explicitly detailed in the provided information, but the FLU 2009 VFA program suggests the procurement of influenza-related vaccines, treatments, or related supplies and services. Additional details regarding task orders, price lists, or the original solicitation are not available in the given materials.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | -$670 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | -$394,287 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $604,696 | |
| Supplemental Agreement for work within scope | $1,662,313 | |
| Original award | $636,821 |
Quick answers
Who was awarded contract HHSD200200929439I?
HHSD200200929439I was awarded to Glaxosmithkline Holdings (Americas) Inc. by CDC Office of Acquisition Services (Centers for Disease Control and Prevention) on April 24, 2009.
How much is contract HHSD200200929439I worth?
HHSD200200929439I's own ceiling is $18,843,626.
Who can order from contract HHSD200200929439I?
HHSD200200929439I is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract HHSD200200929439I competed?
The extent of competition for HHSD200200929439I was full and open competition. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV